Mar 7, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2017-D-6854-0007
The Association for Accessible Medicines (AAM) acknowledges the efforts of the FDA on Docket FDA-2017-N-6854 concerning Good ANDA Submission Practices. We would also like to thank you for the opportunity to share our thoughts on this important public health issue.